Abstract
With the advent of numerous commerical perparations of intravenous immunoglobulin preparations since 1981, it is now possible to administer these preparations in significant quantities to cause elevation of serum immunoglobulin levels both in patients with antibody-deficient states and in those with normal circulating immunoglobulin levels. This led to a report of dramatic improvement of thrombocytopenia in a child with agammaglobulin following the use of intravenous immunoglobulin preparations for recurrent infections, and further studies in both children and adults with associated symptoms suggested therapeutic efficacy of intravenous immunoglobulin preparations in controlling autoimmune symptoms.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 155-173 |
| Number of pages | 19 |
| Journal | Rheumatic Disease Clinics of North America |
| Volume | 22 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 1 1996 |
ASJC Scopus subject areas
- Rheumatology
Fingerprint Dive into the research topics of 'Intravenous immunoglobulin in rheumatic disease'. Together they form a unique fingerprint.
Cite this
Klassen, L. W., Calabrese, L. H., & Laxer, R. M. (1996). Intravenous immunoglobulin in rheumatic disease. Rheumatic Disease Clinics of North America, 22(1), 155-173. https://doi.org/10.1016/S0889-857X(05)70267-2